Okayama University


Okayama University Medical Research Updates(OU-MRU) Vol.92

July 15, 2021

Source: Okayama University (JAPAN), Public Relations Division
For immediate release: 15 July 2021
Okayama University research: Numerical modelling to assist the development of a retinal prosthesis

(Okayama, 15 July) Researchers at Okayama University report in the Journal of Neural Engineering how numerical modelling provides insights into the functioning of a candidate retinal prosthesis for restoring vision in blind people. The model shows that the prosthesis is likely capable of triggering the right electrical responses needed for generating vision in ambient conditions.

Retinal prostheses are a promising approach for restoring vision in patients suffering from diseases causing blindness. In retinitis pigmentosa, blindness is caused by dying photoreceptor cells, which form one of several cell layers in the mammalian retina. At Okayama University, a retinal prosthesis called Okayama University-type retinal prosthesis (OUReP) has been developed for treating retinitis pigmentosa and similar diseases. It has been successfully implanted in rat and monkey eyes. The key component of OUReP are organic molecules that can convert light into electric potentials. While it has been demonstrated that this conversion process indeed happens in an implant, the precise mechanism of how it stimulates a degenerated retina is not known. Now, Associate professor UCHIDA Tetsuya and Professor MATSUO Toshihiko (M.D.) from Okayama University and colleagues have modelled the visual response of OUReP. The results show that the prosthesis has the potential to replace a defect photoreceptor layer.

The scientists modelled the eye, implanted with OUReP, as a cylindrically symmetric layered system. Each layer has a particular thickness and conductivity; OUReP replaces the photoreceptor layer. Particular attention was given to the bipolar cells of the retina, which transmit electrical signals from the photoreceptors/OUReP further down the eye. The researchers took the role of ion channels into account; these consist of membrane proteins leaving pores for ions to pass through, regulating the membrane’s electric potential. A total of 10 such channels was incorporated into the model.

The eye-with-implant model of Associate professor Uchida and colleagues can be seen as a big, complicated electric circuit with many components. Its physical behavior can be described by a set of equations that describe the underlying electrical process — the evolution of electric currents and voltages throughout the whole system. The equations are solved by the so-called finite element method, which divides the full system into many small units for which physical parameters can be more easily computed.

Numerically solving the model enabled the scientists to obtain insights into the photoresponsitivity of OUReP — that is, how well the prosthesis responds to light — and the spatial distribution of the electric potential generated at the OUReP surface. Other aspects that could be studied include how the size of the modelled bipolar cells or the precise position of the OUReP influence performance.

The main conclusion of Associate professor Uchida and colleagues is that stimulation of OUReP with bright environmental light results in an electrical potential large enough to trigger a response in the retinal bipolar cell layer that is typical for mammalian eyes. Another important finding is that this response is larger when the gap between the implant and the cells is smaller. The researchers conclude that “the results of this study can give further insights into improving the efficacy of sub-retinal implants of similar design as OUReP”.

Okayama University-type retinal prosthesis (OUReP) consists of a material that mimics the function of photoreceptor cells present in mammalian eyes: phototransduction, the conversion of light into neuron signals triggering biological processes. The main component of OUReP are so-called 2-[2-[4-(dibutylamino)phenyl]ethenyl]-3-carboxymethylbenzothiazolium bromide molecules, which are photoelectric dye molecules that can convert light into electric potentials. These molecules are attached to the surface of a thin polyethylene film; the resulting OUReP film can be used as an implant replacing non-functioning photoreceptor cells. OUReP is a particularly promising prosthesis material for situations where other retinal neuron cells (converting electric potentials into neuron signals) are still active. This is the case for the disease retinitis pigmentosa.
Associate professor UCHIDA Tetsuya and Professor MATSUO Toshihiko from Okayama University and colleagues have now modelled the physical processes happening in OUReP when implanted as a replacement of photoreceptors in a mammalian eye.

Retinitis pigmentosa: Retinitis pigmentosa is a disease, usually inherited, causing loss of vision. The pathology’s underlying mechanism is the progressive loss of photoreceptor cells in the eye — first rod cells die, then cone cells. It becomes manifest in diagnosis as dark pigment spots in the retina. Symptoms of the disease include difficulty in seeing at night and decreased side vision, which may lead to ‘tunnel vision’. The symptoms usually develop already in childhood.
There is at present no cure for retinitis pigmentosa, but the use of retinal implants such as OUReP, developed at Okayama University, holds promise.

Koichiro Yamashita, Prathima Sundaram, Tetsuya Uchida, Toshihiko Matsuo & Willy Wong. Modelling the visual response to an OUReP retinal prosthesis with photoelectric dye coupled to polyethylene film. J. Neural Eng. 18, 045006 (2021).
DOI: 10.1088/1741-2552/abf892

Reference (Okayama Univ. e-Bulletin): Dr. MATSUO & Dr.UCHIDA’s team
e-Bulletin Vol.8:Photoelectric dye-coupled thin film as a novel type of retinal prosthesis
OU-MRU Vol.8:Light-responsive dye stimulates sight in genetically blind patients
OU-MRU Vol.39:Successful test of retinal prosthesis implanted in rats
OU-MRU Vol.47:Candidate genes for eye misalignment identified
OU-MRU Vol.53:Successful implantation and testing of retinal prosthesis in monkey eyes with retinal degeneration
OU-MRU Vol.70:Prosthetics for Retinal Stimulation
OU-MRU Vol.73:Primary intraocular lymphoma does not always spread to the central nervous system
OU-MRU Vol.90:High levels of television exposure affect visual acuity in children

Correspondence to
Associate Professor UCHIDA Tetsuya, Ph.D.
Division of Applied Chemistry,
Graduate School of Natural Science and Technology,
Okayama University, 3-1-1 Tsushima-Naka, Kita-ku,
Okayama 700-8530, Japan.
E-mail: tuchida(a)cc.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.

Professor MATSUO Toshihiko, M.D., Ph.D.
Ophthalmology, Okayama University Hospital and
Graduate School of Interdisciplinary Science and Engineering
in Health Systems,
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
E-mail: matsuot(a)cc.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.

Further information
Okayama University
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations Division
E-mail: www-adm(a) adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
Website: //www.okayama-u.ac.jp/index_e.html
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
We love OKAYAMA UNIVERSITY: https://www.youtube.com/watch?v=7cXlttQIk3E
Okayama University Image Movie(2020)
Okayama University supports the Sustainable Development Goals: https://sdgs.okayama-u.ac.jp/en/

Okayama University Medical Research Updates (OU-MRU)
The whole volume : OU-MRU (1- )
Vol.1:Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testing
Vol.2:Ensuring a cool recovery from cardiac arrest
Vol.3:Organ regeneration research leaps forward
Vol.4:Cardiac mechanosensitive integrator
Vol.5:Cell injections get to the heart of congenital defects
Vol.6:Fourth key molecule identified in bone development
Vol.7:Anticancer virus solution provides an alternative to surgery
Vol.8:Light-responsive dye stimulates sight in genetically blind patients
Vol.9:Diabetes drug helps towards immunity against cancer
Vol.10:Enzyme-inhibitors treat drug-resistant epilepsy
Vol.11:Compound-protein combination shows promise for arthritis treatment
Vol.12:Molecular features of the circadian clock system in fruit flies
Vol.13:Peptide directs artificial tissue growth
Vol.14:Simplified boron compound may treat brain tumours
Vol.15:Metamaterial absorbers for infrared inspection technologies
Vol.16:Epigenetics research traces how crickets restore lost limbs
Vol.17:Cell research shows pathway for suppressing hepatitis B virus
Vol.18:Therapeutic protein targets liver disease
Vol.19:Study links signalling protein to osteoarthritis
Vol.20:Lack of enzyme promotes fatty liver disease in thin patients
Vol.21:Combined gene transduction and light therapy targets gastric cancer
Vol.22:Medical supportive device for hemodialysis catheter puncture
Vol.23:Development of low cost oral inactivated vaccines for dysentery
Vol.24:Sticky molecules to tackle obesity and diabetes
Vol.25:Self-administered aroma foot massage may reduce symptoms of anxiety
Vol.26:Protein for preventing heart failure
Vol.27:Keeping cells in shape to fight sepsis
Vol.28:Viral-based therapy for bone cancer
Vol.29:Photoreactive compound allows protein synthesis control with light
Vol.30:Cancer stem cells’ role in tumor growth revealed
Vol.31:Prevention of RNA virus replication
Vol.32:Enzyme target for slowing bladder cancer invasion
Vol.33:Attacking tumors from the inside
Vol.34:Novel mouse model for studying pancreatic cancer
Vol.35:Potential cause of Lafora disease revealed
Vol.36:Overloading of protein localization triggers cellular defects
Vol.37:Protein dosage compensation mechanism unravelled
Vol.38:Bioengineered tooth restoration in a large mammal
Vol.39:Successful test of retinal prosthesis implanted in rats
Vol.40:Antibodies prolong seizure latency in epileptic mice
Vol.41:Inorganic biomaterials for soft-tissue adhesion
Vol.42:Potential drug for treating chronic pain with few side effects
Vol.43:Potential origin of cancer-associated cells revealed
Vol.44:Protection from plant extracts
Vol.45:Link between biological-clock disturbance and brain dysfunction uncovered
Vol.46:New method for suppressing lung cancer oncogene
Vol.47:Candidate genes for eye misalignment identified
Vol.48:Nanotechnology-based approach to cancer virotherapy
Vol.49:Cell membrane as material for bone formation
Vol.50:Iron removal as a potential cancer therapy
Vol.51:Potential of 3D nanoenvironments for experimental cancer
Vol.52:A protein found on the surface of cells plays an integral role in tumor growth and sustenance
Vol.53:Successful implantation and testing of retinal prosthesis in monkey eyes with retinal degeneration
Vol.54:Measuring ion concentration in solutions for clinical and environmental research
Vol.55:Diabetic kidney disease: new biomarkers improve the prediction of the renal prognosis
Vol.56:New device for assisting accurate hemodialysis catheter placement
Vol.57:Possible link between excess chewing muscle activity and dental disease
Vol.58:Insights into mechanisms governing the resistance to the anti-cancer medication cetuximab
Vol.59:Role of commensal flora in periodontal immune response investigated
Vol.60:Role of commensal microbiota in bone remodeling
Vol.61:Mechanical stress affects normal bone development
Vol.62:3D tissue model offers insights into treating pancreatic cancer
Vol.63:Promising biomarker for vascular disease relapse revealed
Vol.64:Inflammation in the brain enhances the side-effects of hypnotic medication
Vol.65:Game changer: How do bacteria play Tag ?
Vol.66:Is too much protein a bad thing?
Vol.67:Technology to rapidly detect cancer markers for cancer diagnosis
Vol.68:Improving the diagnosis of pancreatic cancer
Vol.69:Early gastric cancer endoscopic diagnosis system using artificial intelligence
Vol.70:Prosthetics for Retinal Stimulation
Vol.71:The nervous system can contribute to breast cancer progression
Vol.72:Synthetic compound provides fast screening for potential drugs
Vol.73:Primary intraocular lymphoma does not always spread to the central nervous system
Vol.74:Rising from the ashes—dead brain cells can be regenerated after traumatic injury
Vol.75:More than just daily supplements — herbal medicines can treat stomach disorders
Vol.76:The molecular pathogenesis of muscular dystrophy-associated cardiomyopathy
Vol.77:Green leafy vegetables contain a compound which can fight cancer cells
Vol.78:Disrupting blood supply to tumors as a new strategy to treat oral cancer
Vol.79:Novel blood-based markers to detect Alzheimer’s disease
Vol.80:A novel 3D cell culture model sheds light on the mechanisms driving fibrosis in pancreatic cancer
Vol.81:Innovative method for determining carcinogenicity of chemicals using iPS cells
Vol.82:Making memories — the workings of a neuron revealed
Vol.83:Skipping a beat — a novel method to study heart attacks
Vol.84:Friend to Foe—When Harmless Bacteria Turn Toxic
Vol.85:Promising imaging method for the early detection of dental caries
Vol.86:Plates and belts — a toolkit to prevent accidental falls during invasive vascular proceduresa
Vol.87:Therapeutic potential of stem cells for treating neurodegenerative disease
Vol.88:Nanotechnology for making cancer drugs more accessible to the brain
Vol.89:Studying Parkinson’s disease with face-recognition software
Vol.90:High levels of television exposure affect visual acuity in children
Vol.91:Meeting high demand: Increasing the efficiency of antiviral drug production in bacteria